Brief: Hansoh Pharmaceutical Says Units Entered Into Exclusive License And Collaboration Agreement With OliX Pharmaceuticals
12/10/2021 02:55
Oct 12 (Reuters) - Hansoh Pharmaceutical Group Company Ltd
3692.HK :
* ON OCT 11, UNITS ENTERED INTO EXCLUSIVE LICENSE AND
COLLABORATION AGREEMENT WITH OLIX PHARMACEUTICALS, INC.
* OLIX PHARMACEUTICALS WILL RECEIVE INITIAL UPFRONT PAYMENT
OF
US$6.5 MILLION
Further company coverage: 226950.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals - Olx501a Shows 29.2% Visceral Fat Reduction Versus 10.0% With Comparator In Obese Non-Human Primates
Brief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug